Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (161-170 of 325) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemiaGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
British Journal of Haematology|February 16, 2008
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialTait D Shanafelt, Susan M Geyer, Nancy D Bone, et al.
British Journal of Haematology|April 1, 2008
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaClive S Zent, Wei Ding, Susan M Schwager, et al.
Scientific Reports|April 16, 2021
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemiaShulan Tian, Henan Zhang, Pan Zhang, et al.
Cancer Research|February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group studyRafael Fonseca, David Harrington, Martin M Oken, et al.
Blood Cancer Journal|February 19, 2021
Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistanceSutapa Sinha, Charla R Secreto, Justin C Boysen, et al.
Cytometry. Part B, Clinical Cytometry|June 23, 2010
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entityRoxana S Dronca, Dragan Jevremovic, Curtis A Hanson, et al.
Leukemia & Lymphoma|October 9, 2009
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosisClive S Zent, Wei Ding, Megan S Reinalda, et al.
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Pageof 33

Showing results (161-170 of 325) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemiaGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
British Journal of Haematology|February 16, 2008
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialTait D Shanafelt, Susan M Geyer, Nancy D Bone, et al.
British Journal of Haematology|April 1, 2008
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaClive S Zent, Wei Ding, Susan M Schwager, et al.
Scientific Reports|April 16, 2021
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemiaShulan Tian, Henan Zhang, Pan Zhang, et al.
Cancer Research|February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group studyRafael Fonseca, David Harrington, Martin M Oken, et al.
Blood Cancer Journal|February 19, 2021
Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistanceSutapa Sinha, Charla R Secreto, Justin C Boysen, et al.
Cytometry. Part B, Clinical Cytometry|June 23, 2010
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entityRoxana S Dronca, Dragan Jevremovic, Curtis A Hanson, et al.
Leukemia & Lymphoma|October 9, 2009
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosisClive S Zent, Wei Ding, Megan S Reinalda, et al.
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Pageof 33